RxDoctor Payments Data

Ashley Dean, MD

Family Medicine · Lexington, SCNPI 1134417694

Payments from drug & device makers

$496in general payments, 2019–2025

Across 37 payments — averaging $13.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$82
  • Amgen$70
  • AstraZeneca$63
  • Novo Nordisk$51
  • Novartis$50
  • Exact Sciences$36
  • plus $143 from 7 others

What the payments were for

  • Food & beverage$496100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$496 in reported general payments places this provider in the 50th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$86,829
Medicare patients
188
Services billed
1,398

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide39$72,391
MounjaroTirzepatide54$57,120
EliquisApixaban35$41,135
TrulicityDulaglutide16$33,078
FarxigaDapagliflozin Propanediol34$31,120
JardianceEmpagliflozin21$23,346
JanuviaSitagliptin Phosphate23$14,537
MyrbetriqMirabegron14$10,745
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog15$7,801
Tresiba Flextouch U-100Insulin Degludec13$5,393
SymbicortBudesonide/Formoterol Fumarate14$3,549
Atorvastatin Calcium260$2,878
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$2,875
Levothyroxine Sodium165$2,475
Duloxetine Hcl43$2,267

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$51$72,39139 claims
AstraZenecaFarxiga, Symbicort$63$34,66948 claims
Boehringer IngelheimJardiance$23$23,34621 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Lexington

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →